EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Recombinant Amelogenin as a Potential Alternative to Enamel Matrix Derivatives in Periodontal Regeneration: A Scoping Review of Its Biological Activity, Synthesis and Delivery Systems

Jie Dan Denny Luo iD, Jennifer Mardini iD, Raymond Lee, Fariba Dehghani iD, Aaron Schindeler iD

Clinical and Experimental Dental Research · 2026

DOI: 10.1002/cre2.70325 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical and Experimental Dental Research, 2026. Verfasst von Jie Dan Denny Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Amelogenin, Regeneration, Guided Tissue Regeneration, Periodontal, Periodontium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this review is to evaluate the existing literature on the regenerative potential of recombinant amelogenin, with a particular emphasis on the biological activity, synthesis, and delivery systems relevant to periodontal regeneration. Materials and Methods A comprehensive literature search was conducted across PubMed, Ovid MEDLINE, Scopus and Web of Science to identify studies on recombinant amelogenin for periodontal regeneration. Inclusion criteria encompassed in vitro and animal model studies reporting on cellular growth, regeneration markers, tissue repair and clinical improvements. Data extraction focused on study design, protein source, delivery system, experimental model, and reported biological outcomes. The review was conducted in accordance with the PRISMA‐ScR guidelines and supplemented by a narrative synthesis of the preclinical literature.

Results

The literature search included 23 studies comprising predominantly preclinical cell culture and in vivo mouse studies. Recombinant amelogenin was evaluated across diverse experimental systems and delivery methods, most frequently by direct dissolution in culture media, with fewer studies using injectable hydrogels or scaffold‑based carriers. Although most investigations reported biological activity attributable to recombinant amelogenin, the outcome measures, experimental models, and formulation strategies varied substantially, limiting direct comparison across studies.

Conclusion

Recombinant amelogenin shows consistent preclinical activity supporting its biological plausibility as a regenerative agent. However, evidence remains largely preclinical and heterogeneous. Future studies should employ standardised models, optimised delivery systems, and direct comparisons with established therapies to clarify its translational potential in periodontal regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmelogeninRegenerationGuided Tissue Regeneration, PeriodontalPeriodontiumAnimalsHumansRecombinant ProteinsDrug Delivery Systems

Stichwörter der Autor:innen

in vitroin vivo modelsperiodontal regenerationrecombinant amelogenin

Substanzen

AmelogeninRecombinant Proteins

Autor:innen und Institutionen

  • School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, Australia.
  • Faculty of Medicine and Health, Sydney Dental School, University of Sydney, Sydney, Australia.
  • Bioengineering and Molecular Medicine Laboratory, The Children's Hospital at Westmead and Westmead Institute for Medical Research, Sydney, Australia.

ORCID-Profile: Jie Dan Denny Luo, Jennifer Mardini, Fariba Dehghani, Aaron Schindeler

Zitieren

APA

Luo, J. D. D., Mardini, J., Lee, R., Dehghani, F., & Schindeler, A. (2026). Recombinant Amelogenin as a Potential Alternative to Enamel Matrix Derivatives in Periodontal Regeneration: A Scoping Review of Its Biological Activity, Synthesis and Delivery Systems. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.70325

Vancouver

Luo JDD, Mardini J, Lee R, Dehghani F, Schindeler A. Recombinant Amelogenin as a Potential Alternative to Enamel Matrix Derivatives in Periodontal Regeneration: A Scoping Review of Its Biological Activity, Synthesis and Delivery Systems. Clinical and Experimental Dental Research. 2026. doi:10.1002/cre2.70325

BibTeX
@article{Luo2026,
  author = {Luo, Jie Dan Denny and Mardini, Jennifer and Lee, Raymond and Dehghani, Fariba and Schindeler, Aaron},
  title = {Recombinant Amelogenin as a Potential Alternative to Enamel Matrix Derivatives in Periodontal Regeneration: A Scoping Review of Its Biological Activity, Synthesis and Delivery Systems},
  journal = {Clinical and Experimental Dental Research},
  year = {2026},
  doi = {10.1002/cre2.70325}
}
Kostenlos starten →